envelope and is composed by 3 proteins, such as S (small, S domains), M (medium, preS2+S) and L (large, preS1+preS2+S) codified by only one open reading frame. The S-HBs protein is the major component of the virion envelope and the subviral HBsAg particles, such as filaments and spheres, while virions and filaments contain more M-HBs, and in particular, more L-HBs proteins than spheres. 1, 2 In infected individuals, subviral particles are present in at least 100-fold excess over virions. 3 The processing of production and secretion of HBsAg is complex, and the comparative proportion of each S-, M-, L-HBsAg component in the serum and liver varies according to the state of HBV replication. 4 The recent growing interest in quantitative analysis of HBsAg as a clinical parameter has been based on several studies that observed its relationship with serum and liver HBV DNA. [5] [6] [7] In fact, quantification of HBsAg was introduced more than 20 years ago, but its clinical usefulness has been questioned due to the lack of appropriate standardization. 8 response to oral nucleos(t)ide analogues remains to be determined in future studies.
The significance of HBsAg levels in the natural course of HBV infection is another key issue in need of detailed evaluation.
In fact, HBV replication and HBsAg/HBV-DNA production go through a complex process, which accompanies highly dynamic changes during the long-lasting interaction between virus and host immunity. More recently, the role of quantification of serum HBsAg has been explored in a subset of European and Asian HBV-infected cohorts. The overall correlation between HBsAg and HBV DNA levels was noted in both study populations. 8, 11 However, when it was analyzed separately by different phases of chronic HBV infection or by HBV genotypes, the correlation was shown to become weak or negligible. 8, 11 More specificially, a positive correlation between serum HBsAg and HBV DNA levels was only observed in the early phases of infection, but disappeared in the late phases (HBeAg-negative status). Indeed, the correlation was totally absent for patients with HBV genotype A. HBsAg between its three components of L, M, and S proteins, in this subset of patients. 4 Thus, the relationships between HBsAg and HBV DNA levels should be understood in light of the predominant pathway of HBsAg production versus viral replication in the course of chronic HBV infection (Fig. 1) .
It is well known that nearly all (>95%) chronic HBV carriers in Korea have genotype C, [12] [13] [14] [15] [16] which is associated with a high prevalence of basal core promoter mutants, even before HBeAg seroconversion. [14] [15] [16] for HBsAg (<1,000 IU/mL) and HBV DNA (<2,000 IU/mL) yielded the most accurate identification of inactive carriers with a 94.3% diagnostic accuracy, comparable with that of long-term tight monitoring. 21 A recent Korean study by Park et al., 19 in which 102 HBeAg-negative patients were recruited, also attempted to determine the value of HBsAg quantification for determining outcome of HBeAg-negative hepatitis. In this study, the cut-off value for HBsAg that provided the best predictive accuracy to discriminate inactive carriers from active carriers was 3.25 log IU/mL for the non-cirrhosis group and 2.57 log IU/mL for the cirrhosis group (Table 1) 
